In your opinion, what is the most important risk associated with 5-aminosalicylate therapy in patients with inflammatory bowel disease? Let us know by taking the poll!
Gastroenterology Consultant published content on various topics throughout 2019. Which topic do you want to see more of this year? Take our poll to voice your opinion!
We want to hear from you, our loyal readership of Gastroenterology Consultant. Tell us what topics you're interested in, and you will see more content covered in that topic!
